Subjects: “...clinical trial [publication type]...”
Access document (1)
Access document (2)

“...OBJECTIVE: To compare cardiopulmonary and sedative effects following administration...”
Access document (1)
Access document (2)

“..., aiming to decrease the hematocrit to 33%. Rotational thromboelastometry and other coagulation variables...”
Access document (1)
Access document (2)

Subjects: “...Clinical evolution, Brazil...”
Access document

“...Background-Aerobic training has a number of well known beneficial effects in both normal and...”
Access document (1)
Access document (2)

“... stratification and clinical decision-making in patients with HF under beta-blocker therapy....”
Access document (1)
Access document (2)

“... peptide need to be optimized for clinical use. To evaluate the effects of dimerization on the structure...”
Access document (1)
Access document (2)

“...Purpose: The aim of this study was to assess demographic, clinical characteristics and outcomes...”
Access document

“...Medicinal plants Equisetum arvense and Camellia sinensis are popularly used in Brazil to treat...”
Access document

“...Objectives To investigate the effects of levomepromazine and different desflurane concentrations...”
Access document (1)
Access document (2)

“... of G. De la Torre Canales, and the Sao Paulo Research Foundation (FAPESP)—Brazil for the PhD. scholarship of V.R.M...”
Access document

“... propofol is a venous anesthetic utilized for anesthesia induction and maintenance, and reportedly...”
Access document (1)
Access document (2)

“... studies on the corrosion of titanium dental implants and consequent clinical detrimental effects to the...”
Access document

Access document

“... fascicles of the orbicularis oris muscle was detected, with a decrease of EMG activity between the T0 and...”
Access document (1)
Access document (2)

Subjects: “...Clinical safety...”
Access document (1)
Access document (2)

“... healing and improvement, but the effects in infectious keratoconjunctivitis in ruminants are uncertain...”
Access document (1)
Access document (2)

“...).Results: After treatment, there was a decrease in the symptomatology in both estrogen and isoflavone...”
Access document (1)
Access document (2)

“...; 3 groups: P = .001), and a decrease in the timed up-and-go time (2 groups: P = .04; 3 groups: P = .0001...”
Access document (1)
Access document (2)

“... rate. DESIGN, SETTING, AND PARTICIPANTS In this randomized clinical trial designed in 2015 and...”
Access document (1)
Access document (2)